1. Home
  2. PLYM vs EVO Comparison

PLYM vs EVO Comparison

Compare PLYM & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plymouth Industrial REIT Inc.

PLYM

Plymouth Industrial REIT Inc.

HOLD

Current Price

$21.88

Market Cap

993.0M

Sector

Real Estate

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLYM
EVO
Founded
2011
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
993.0M
1.1B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
PLYM
EVO
Price
$21.88
$2.98
Analyst Decision
Hold
Strong Buy
Analyst Count
8
1
Target Price
$21.14
$7.00
AVG Volume (30 Days)
1.9M
107.8K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
4.39%
N/A
EPS Growth
11196.82
N/A
EPS
2.04
N/A
Revenue
$163,681,000.00
$887,396,457.00
Revenue This Year
$1.88
N/A
Revenue Next Year
$9.24
$8.80
P/E Ratio
$10.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.70
$2.84
52 Week High
$22.74
$5.10

Technical Indicators

Market Signals
Indicator
PLYM
EVO
Relative Strength Index (RSI) 46.94 40.01
Support Level $21.77 $2.86
Resistance Level $21.90 $3.09
Average True Range (ATR) 0.14 0.10
MACD -0.03 0.01
Stochastic Oscillator 12.37 24.49

Price Performance

Historical Comparison
PLYM
EVO

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: